from the IV MB, by PauvrePapillon:
>>CyberKnife for Breast Cancer
Département de radiothérapie, Centre Antoine Lacassagne, Nice, France now using CyberKnife with Synchrony for Breast Cancer
This is a market that was not anticipated by management. Their estimate of 3,500 centers in the U.S. (and 3,500 additional Centers worldwide) to handle patient demand did not include CyberKnife treatment for breast cancer.
From Robotic Stereotactic Radioablation Concomitant with Neo-Adjuvant Chemotherapy for Breast Tumors
“The study showed the feasibility of irradiation with RSR combined with chemotherapy and surgery for breast tumors. There was no skin toxicity at a dose of 19.5 Gy or 22.5 Gy delivered in three fractions combined with chemotherapy. Lack of toxicity suggested that the dose could be increased further. Pathologic response was acceptable.”
http://www.redjournal.org/article/S0360-3016(09)00026-1/abstract
Tuesday, May 5, 2009
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment